Investing.com - Qiagen (NYSE:QGEN) reported on Monday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Qiagen announced earnings per share of $0.5466 on revenue of $469.75M. Analysts polled by Investing.com anticipated EPS of $0.5252 on revenue of $464.11M.
Qiagen shares are down 5% from the beginning of the year, still down 14.71% from its 52 week high of $46.95 set on October 13, 2020. They are under-performing the STOXX 600 which is up 10.25% from the start of the year.
Qiagen follows other major Healthcare sector earnings this month
Qiagen's report follows an earnings missed by Siemens Healthineers on Monday, who reported EPS of $0.44 on revenue of $3.97B, compared to forecasts EPS of $0.4647 on revenue of $3.9B.
Dermapharm had missed expectations on April 13 with first quarter EPS of $0.45 on revenue of $216.7M, compared to forecast for EPS of $0.51 on revenue of $208.85M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar